May 2004
Volume 45, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2004
Citicoline and/or lithium rescue retinal ganglion cells following callibrated partial optic nerve crush in the rat
Author Affiliations & Notes
  • R.A. Rejdak
    Pathophysiology Vision, University Eye Hospital, Tubingen, Germany
  • F. Schuettauf
    Pathophysiology Vision, University Eye Hospital, Tubingen, Germany
  • C. Lehaci
    Pathophysiology Vision, University Eye Hospital, Tubingen, Germany
  • S. Thaler
    Pathophysiology Vision, University Eye Hospital, Tubingen, Germany
  • S. Bolz
    Pathophysiology Vision, University Eye Hospital, Tubingen, Germany
  • T. Zarnowski
    Tadeusz Krwawicz Chair of Ophthalmology and 1st Eye Hospital, Medical University of Lublin, Lublin, Poland
  • Z. Zagorski
    Tadeusz Krwawicz Chair of Ophthalmology and 1st Eye Hospital, Medical University of Lublin, Lublin, Poland
  • P. Grieb
    Laboratory of Experimental Pharmacology, Medical Research Centre, Polish Academy of Science, Warsaw, Poland
  • E. Zrenner
    Pathophysiology Vision, University Eye Hospital, Tubingen, Germany
  • Footnotes
    Commercial Relationships  R.A. Rejdak, None; F. Schuettauf, None; C. Lehaci, None; S. Thaler, None; S. Bolz, None; T. Zarnowski, None; Z. Zagorski, None; P. Grieb, None; E. Zrenner, None.
  • Footnotes
    Support  QLK2–CT–2002–51562
Investigative Ophthalmology & Visual Science May 2004, Vol.45, 827. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      R.A. Rejdak, F. Schuettauf, C. Lehaci, S. Thaler, S. Bolz, T. Zarnowski, Z. Zagorski, P. Grieb, E. Zrenner; Citicoline and/or lithium rescue retinal ganglion cells following callibrated partial optic nerve crush in the rat . Invest. Ophthalmol. Vis. Sci. 2004;45(13):827.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: Citicoline (cytidine–5’–diphosphocholine), a neuroprotectant effective in animal models of CNS ischemia and trauma, has been shown to prevent RGC degeneration in vitro. Lithium, a well–known mood stabilizer, has been found to promote RGC survival and axon regeneration. We evaluated protection offered by citicoline sodium and/or lithium chloride systemic treatment to the retinal ganglion cells (RGC) in a model of callibrated partial optic nerve crush (PONC) in the rat. Methods: Citicoline sodium (1 g/kg/day for 7 days and 300 mg/kg/day for subsequent 2 weeks) and/or lithium chloride (30 mg/kg/day over 3–week period) were given after induction of retinal ganglion cells (RGC) loss in a model of calibrated partial optic nerve crush (PONC) in the rat. RGC retrogradely labeled with Fluorogold were counted; all data are expressed as percent of the RGC count in the respective SHAM–treated group. Results: PONC resulted in the decrease in the number of labelled RGC per square mm of retina to 44.8% after 7 days and to 28.0% after 3 weeks. Citicoline treatment attenuated this decrease to 70.1% and 53.4%. Treatment with lithium chloride was more effective, 77.3% and 76.8% RGC remained intact. Treatment with the combination of the said doses of citicoline and lithium chloride resulted in the labelling of 88.3% and 73.5% of RGC. Conclusion: Our data indicate that: 1. besides acute axotomy, PONC is followed by a delayed neurodegenerative process which further eliminates RGCs and/or disconnects them from superior colliculi; 2. treatment with both citicoline and lithium spares a significant number of RGC connected to superior colliculi; 3. the possibility that these drugs act through different but complementary mechanisms (eg., neuroprotection and axonal regeneration) requires further study. Sopported by MCIF for R.Rejdak QLK2–CT–2002–51562

Keywords: neuroprotection • ganglion cells • trauma 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×